Michael Landsittel

Insider Reports History

Entity
Individual
Location
Blueprint Medicines Corp., 214 First Street, Suite 340/350, Cambridge, MA
Signature
/s/ Melissa Masse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Landsittel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp CHIEF FINANCIAL OFFICER Common Stock 67.2K $6.4M $95.23 Aug 15, 2024 Direct
Blueprint Medicines Corp CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 0 May 8, 2024 Direct

Insider Reports Filed by Michael Landsittel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Aug 15, 2024 1 -$420K 4 Aug 19, 2024 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp May 15, 2024 2 -$412K 4 May 17, 2024 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp May 8, 2024 4 $65.3K 4 May 10, 2024 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp May 2, 2024 3 -$690K 4 May 6, 2024 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 28, 2024 3 -$295K 4 Apr 1, 2024 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 15, 2024 8 -$1.03M 4 Mar 19, 2024 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 7, 2024 1 -$454K 4 Mar 11, 2024 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 1, 2024 2 $0 4 Mar 6, 2024 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 6, 2023 2 -$137K 4 Mar 8, 2023 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 1, 2023 2 $0 4 Mar 3, 2023 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 3, 2022 2 -$139K 4 Mar 8, 2022 CHIEF FINANCIAL OFFICER
BPMC Blueprint Medicines Corp Mar 1, 2022 2 $0 4 Mar 3, 2022 CHIEF FINANCIAL OFFICER